Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nutex HealthFRA:5LF +3.77%57 EV-to-OCF is 5.66 as of Aug. 28, 2026, which is 69% below its 10-year median of 18.23. GuruFocus rates FRA:5LF with a GF Score™ of 57/100 and a GF Value™ of €70.29 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 685 Healthcare Providers & Services companies, Nutex Health ranks better than 61.02% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Nutex Health's Enterprise Value is €1,358.2 Mil.
Nutex Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €239.9 Mil. Therefore, Nutex Health's EV-to-OCF for today is 5.66.
The historical rank and industry rank for Nutex Health's EV-to-OCF or its related term are showing as below:
FRA:5LF'
s EV-to-OCF Range Over the Past 10 Years
Min: -314.86 Med: 18.23 Max: 328.68
Current: 5.66
During the past 7 years, the highest EV-to-OCF of Nutex Health was 328.68. The lowest was -314.86. And the median was 18.23.
FRA:5LF's EV-to-OCF is ranked better than 61.02% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 8.93
vs FRA:5LF: 5.66
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nutex Health's PE Ratio (TTM) for today is calculated as:
Nutex Health's share price for today is €165.00.
Nutex Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €21.675.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Nutex Health EV-to-OCF Related Terms
Nutex Health EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Nutex Health's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nutex Health's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutex Health EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Nutex Health's EV-to-OCF falls into.
Nutex Health's current Enterprise Value is €1,358.2 Mil.
Nutex Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €239.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nutex Health (FRA:5LF) has a EV-to-OCF of 5.66 as of Aug. 28, 2026. This is 69% below median its historical median of 18.23. According to the industry distribution chart, Nutex Health ranks #267 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 39%.
Is Nutex Health's EV-to-OCF too high?
Nutex Health's current EV-to-OCF of 5.66 is 69% below median its 10-year median of 18.23. The Healthcare Providers & Services industry median EV-to-OCF is 8.93. Nutex Health's value of 5.66 is 36.6% below this industry median. Based on the distribution chart, Nutex Health ranks #267 out of 685 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nutex Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's EV-to-OCF compare to USPH and AMN?
According to the Healthcare Providers & Services industry distribution chart, Nutex Health ranks #267 out of 685 companies for EV-to-OCF. This puts Nutex Health in the upper half of its industry. The industry median EV-to-OCF is 8.93. Nutex Health's value of 5.66 is 36.6% below this benchmark. While the company's 10-year median is 18.23 vs. the industry median of 8.93, Nutex Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.93, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nutex Health's current EV-to-OCF of 5.66 is 36.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutex Health's current EV-to-OCF is 5.66, which is 69% below median its own 10-year median of 18.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (FRA:5LF) is currently considered Significantly Overvalued. The stock's GF Value™ is €70.29, compared to a current price of €165.00 — trading 134.7% above its estimated fair value. The current EV-to-OCF is 5.66, which is 69% below median its 10-year median of 18.23 and 36.6% below the Healthcare Providers & Services industry median of 8.93. Nutex Health's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Nutex Health (FRA:5LF), the current EV-to-OCF is 5.66 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nutex Health (FRA:5LF) Overvalued in 2026?
Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued.
The current stock price of €165.00 is trading 134.7% above its estimated GF Value™ of €70.29.
GuruFocus considers Nutex Health to be Significantly Overvalued.
Key valuation signals for FRA:5LF:
EV-to-OCF: 5.66 (69% below median its 10-year median of 18.23)
GF Value™: €70.29 vs. price of €165.00 (134.7% above fair value)
Industry Position: 36.6% below the Healthcare Providers & Services median (#267 of 685)
No single metric tells the full story. See the FRA:5LF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
57GF Score
Get the complete analysis for FRA:5LF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5LF has been successfully added to your 
